Biotech | May 23, 2022
Crosscope and Farcast Biosciences join efforts to reshape the precision oncology landscape
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
_256_275.jpg)